SCHEMBL20970437

SCHEMBL20970437

CC(C)S(=O)(=O)c1cncc(CC(C)S(=O)(=O)c2cncnc2)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19296769 0.79 ABL1 (0.31) —
SCHEMBL24252515 0.68 ALDH1A1 (0.37) —
SCHEMBL15052712 0.67 S100A9 (0.39) —
SCHEMBL30744210 0.67 HCAR2 (0.37) —
SCHEMBL15870055 0.67 ENPP2 (0.35) —
SCHEMBL7295923 0.66 HCAR2 (0.30) —
SCHEMBL14813131 0.65 CA2 (0.34) —
SCHEMBL13678305 0.65 JAK2 (0.31) —
SCHEMBL27961594 0.65 APLNR (0.50) —
SCHEMBL7295928 0.64 HCAR2 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190127336-A1 SUBSTITUTED QUINAZOLINE COMPOUNDS AND METHODS OF USE ARAXES PHARMA, LLC 2019-05-02 — — US disclosed
Send feedback